New Zealand joins a growing list of countries exploring psychedelic-assisted therapy. In 2023, Australia became the first ...

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Draig Therapeutics has been awarded £107m to advance the development of novel therapies for major neuropsychiatric disorders ...

Staying positive can cut the risk of memory loss in middle age, a 16-year study suggests. Researchers tracked more than ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

According to Ni, ketamine and the products that it breaks down into are released through our urine and can therefore ...